Advancing Global Cancer Research & Training
The Global Cancer Research and Training (GCRT) Program at MSK aims to reduce cancer disparities and improve outcomes worldwide. Formerly named the Global Cancer Disparities Initiatives, the program focuses on research, education, and partnerships that expand access and train future global oncology leaders.
Fueling global partnerships and uniting cancer experts
Philanthropy powered the partnership that led to the establishment of what is now MSK’s GCRT program. Today, this program is bridging the gap between MSK’s cancer experts and communities in Ghana, Kenya, Mexico, and Nigeria.
Ending cancer for life — worldwide
It’s estimated that by 2030, approximately 75% of cancer deaths worldwide will occur in low- and middle-income countries. With your support, the GCRT program can expand its collaborative research initiatives addressing:
- The global cancer burden
- Access to cancer care worldwide
- Unmet needs in underserved communities
Discover how MSK is improving colorectal cancer care in Nigeria.
Watch the video
The impact of the GCRT program
The GCRT Program addresses cancer inequities through collaborative research, global partnerships, and education. MSK works with international institutions to study disparities, strengthen care systems, and train oncology leaders, advancing equity with precision and compassion.
Training global cancer leaders
As cancer rates rise globally — especially in low- and middle-income countries — there’s a critical need for skilled oncology professionals. The GCRT Program trains future cancer leaders through research and international partnerships.
Learn moreDriving cancer research
MSK co-founded the African Research Group for Oncology (ARGO) in 2013 to answer some of the biggest questions about cancer. ARGO is now a National Cancer Institute–recognized research consortium that includes 26 Nigerian institutions.
About ARGOExpanding access to cancer care
The GCRT Program launched Project ECHO (Extension for Community Healthcare Outcomes) to expand cancer care skills for providers in underserved communities, using remote training and mentorship to deliver best-practice oncology services.
See the workHelp MSK advance cancer care, research, and education
The MSK Campaign: Leading Science. Changing Lives.
The MSK community is raising $6 billion by 2030 to accelerate advances across six key strategic initiatives. Learn more and join us in our mission of ending cancer for life.
Learn more about The MSK Campaign